SMW Free Realtime Trade Alerts -- Fast Moving Stocks < $15 -- Join Today for FREE!!

Idera Pharmaceuticals, Inc.

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
Loading IDRA News...
Health Technology » Biotechnology
GILDGilead Sciences, Inc.
CELGCelgene Corporation
BIIBBiogen Inc.
AMGNAmgen Inc.
ILMNIllumina, Inc.
REGNRegeneron Pharmaceuticals, Inc.
ALXNAlexion Pharmaceuticals, Inc.
VRTXVertex Pharmaceuticals Incorporated
SRPTSarepta Therapeutics, Inc.
INCYIncyte Corporation
CLVSClovis Oncology, Inc.
BMRNBioMarin Pharmaceutical Inc.
EXELExelixis, Inc.
ALNYAlnylam Pharmaceuticals, Inc

Company Profile

Idera Pharmaceuticals, Inc. is a clinical stage biotechnology company, which is engaged in discovery, development and commercialization of novel nucleic acid therapeutics to treat patients with serious and life-threatening diseases. Idera's immunotherapy approach is based on the modulation of toll-like receptors (TLRs) while its third-generation antisense technology is designed to inhibit the production of disease-associated proteins by targeting RNA. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal and James B. Wyngaarden in May 25, 1989 and is headquartered in Cambridge, MA.